Navigation Links
NYU College of Nursing's Dr. Anastasi awarded $2.5 million from NIH to study IBS symptom management
Date:8/6/2012

New York University College of Nursing's (NYUCN) Joyce K. Anastasi, PhD, DrNP, FAAN, LAc., the Independence Foundation Endowed Professor and Founding Director of the Division of Special Studies in Symptom Management at NYUCN has been awarded a $2.5 million four-year National Institutes of Health (NIH) grant for the study of "Symptom management for irritable bowel syndrome (IBS) constipation".

The primary aim of the study is to investigate the efficacy of Acupuncture/Moxibustion (Acu/Moxa) in reducing abdominal pain/discomfort and IBS secondary supporting symptoms such as intestinal gas, bloating, and stool consistency. The randomized, blinded, sham/placebo controlled study, with 183 adults diagnosed with IBS-Constipation, will follow the accepted standards of rigorous clinical trials.

"Acu/Moxa , used in traditional Chinese medicine, has been employed successfully to manage various GI disorders including IBS," said Dr. Anastasi. "However, few acupuncture studies have had the necessary rigor to evaluate this therapy," she said.

IBS is the most commonly identified functional bowel disorder afflicting 15% to 20% of North Americans. IBS is defined as abdominal pain/discomfort in the mid or lower gastrointestinal (GI) tract, associated with defecation or a change in bowel patterns with features of disordered defecation.

The chronic symptoms of IBS have been linked with decreased quality of life, decreased work productivity, and increased health care utilization. Few current therapies such as dietary modification, supplements, psychotherapy and pharmacologic agents are proven effective, either singly or in combination. Most [studies] said Dr. Anastasi, "have been limited by size, design and duration of follow-up."

Dr. Anastasi is one of the country's leading clinical scientists in the area of symptom management. Over the past three years, Dr. Anastasi has been awarded three NIH R01s, all of which have contributed to developing rigorously tested, randomized clinical trials using non-invasive interventions to manage chronic and often debilitating symptoms. Her studies provide the foundation to develop clinically meaningful interventions to guide researchers, clinicians and patients to understand the therapeutic benefits of methods such as traditional Chinese medicine.

Dr. Anastasi served on the Advisory Board for the Institute of Medicine's (IOM) report on The Use of Complementary and Alternative Medicine by the American Public. Dr. Anastasi, a nurse scientist, clinical trialist is also an acupuncturist, Diplomate from the NCCAOM. Dr. Anastasi authored and developed the Herbs, Nutraceuticals and Dietary Supplements graduate program funded by the Health Resources and Services Administration (HRSA). She has published extensively in the area of symptom management using non-invasive interventions and has received numerous awards for her contributions and expertise in acupuncture and symptom management research.


'/>"/>

Contact: Christopher James
christopher.james@nyu.edu
212-998-6876
New York University
Source:Eurekalert

Related biology news :

1. UC Berkeley survey shows college campuses can make good bird havens
2. College students work to sterilize air, kill pathogens on buses
3. Study by Haverford College professor reveals unprecedented impact of Deepwater Horizon on deep ocean
4. American College of Rheumatology releases first classification criteria for polymyalagia rheumatica
5. OU research group awarded $9.7 million NIH CoBRE grant in structural biology
6. UC Riverside graduate student awarded Guru Gobind Singh Fellowship
7. $5 million grant awarded to UC Riverside to study immortality
8. UTMB scientists awarded NIH grant for lab-grown lung tissue project
9. Danforth Center awarded $12 million to study drought
10. VESAG mHealth watch awarded CE, ROHS and SAR certifications
11. NOAA scholarship awarded to Jan Vicente to study the impact of ocean acidification on marine sponges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2020)... (PRWEB) , ... July 08, 2020 , ... ... on Cell and Gene Therapy Regulation, An FDAnews Webinar, Wednesday, July 22, 2020 ... a comparability study, but what is the most effective way to complete one? ...
(Date:7/2/2020)... ... July 02, 2020 , ... ... has announced a publication detailing the use of its revolutionary NEXTGENPCR endpoint ... reaction (RT-PCR) in 16 minutes. The article, titled "Ultra-fast one-step RT-PCR protocol ...
(Date:6/28/2020)... ... June 25, 2020 , ... In an upcoming episode scheduled for the ... of Care Testing solutions (POCT). Check local listings for more info. , Today, the ... and are shipped to labs throughout the country. Results are then available several days ...
Breaking Biology News(10 mins):
(Date:8/15/2020)... Ariz. (PRWEB) , ... August 13, 2020 , ... ... on its annual Inc. 5000 list, the most prestigious ranking of the nation’s ... companies within the American economy’s most dynamic segment—its independent small businesses. Intuit, Zappos, ...
(Date:8/3/2020)... ... August 03, 2020 , ... ERT, ... President and CEO has been named one of the 100 most inspiring individuals ... PharmaVoice 100 honorees are selected based on how they have inspired their colleagues ...
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... ... that can combine up to three different materials for use with CRM, neurostimulation, ... up to three materials to meet specific design requirements, performance, and cost criteria; ...
(Date:7/22/2020)... ... ... Join experts from Reed Tech , Gary Saner, Sr. Manager, Information Solutions Life ... webinar on Thursday, August 13, 2020 at 11am EDT (4pm BST/UK). , The ... medical devices, the NMPA has departments dealing with medical device registration (pre-market approvals) and ...
Breaking Biology Technology: